回帖：6    收藏：1    投票：0
回帖：43    收藏：3    投票：0
回帖：9    收藏：4    投票：0
Purpose Farletuzumab is a humanized monoclonal antibody that binds to folate receptor-α, which is highly expressed in ovarian carcinoma and largely absent from normal tissue. Farletuzumab was investigated in a double-blind, randomized phase III study in platinum-sensitive ovarian cancer. Patients and Methods Eligible patients had first recurr
Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement Purpose To endorse the European Association of Urology guideline on muscle-invasive (MIBC) and metastatic bladder cancer. The American Society of Clinical Oncology (ASC
Inherited Mutations in Women With Ovarian Carcinoma Germline mutations in BRCA1 and BRCA2 are relatively common in women with ovarian,
Role of Adjuvant Therapy in a Population-Based Cohort of Patients With Early-Stage Small-Cell Lung Cancer Purpose Data on optima
Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial Backgroun...
Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F In a patient who had metastatic anaplastic lymphoma kinase (A...
Abstract Purpose Breast implant–associated anaplastic large-cell lymphoma (BI-ALCL) is a rare type of T-cell lymphoma that arises around bre...
Background Fludarabine-based chemoimmunotherapy with rituximab is frequently used in patients with indolent and mantle-cell lymphomas who r...
Impact of Age at Primary Breast Cancer on Contraloateral Breast Cancer Risk in BRCA1/2Mutation Carriers Abstract Purpose To determine pros...